| Date | Title | Description |
| 12.11.2025 | Focusing on Industrialisation and Exploring Global Pathways -- The 3rd CREATE Symposium Concludes Successfully | HONG KONG, Nov. 12, 2025 /PRNewswire/ -- How is artificial intelligence revolutionising diagnostic experiences? How can robotics enhance surgical precision? How far are we from achieving universal access to medical AI? What are the latest t... |
| 25.07.2025 | Shanghai Healthcare M&A Fund Takes Strategic Stake in MicroPort Scientific Corporation | HONG KONG SAR – Media OutReach Newswire – 25 July 2025 – MicroPort Scientific Corporation (Stock Code: 00853.HK, “MicroPort”) announced that Shanghai Healthcare M&A Fund (“SHMAF”), a fund managed by SIIC Capital, a subsidiary of SIIC Gr... |
| 09.04.2025 | [In Photos] China's 91st Medical Equipment Fair Opens With Focus on AI+Robots, Others | (Yicai) April 9 -- The 91st China International Medical Equipment Fair kicked off in Shanghai, featuring 13 exhibition halls focusing on six key areas, including innovations in artificial intelligence plus medical robots.
The other five are... |
| 16.03.2025 | China's medical equipment integrates cutting-edge technologies to drive innovation | This photo taken on March 14, 2025 shows a surgical robot demonstration during the 2025 China Medical Equipment Conference & Medical Equipment Exhibition held at Chongqing International Expo Center in Southwest China's Chongqing municip... |
| 20.08.2024 | MicroPort Unit’s Stock Sinks After Chinese Watchdog Queries Inflated Coronary Stent Price | (Yicai) Aug. 20 -- Shares of MicroPort Endovascular MedTech Group, a unit of Chinese medical devices maker MicroPort, plunged after the country’s National Healthcare Security Administration questioned the significantly higher price of one o... |
| 02.04.2024 | Gilbane, Inc. Announces Appointment of William F. McKeon to Board of Directors | William F. McKeon, President & CEO of the Texas Medical Center, joins Gilbane, Inc.'s Board of Directors. (PRNewsfoto/Gilbane, Inc.)
Healthcare chief executive brings global life sciences expertise to Gilbane, a leader in construction s... |
| 13.03.2024 | Bio-Implants Market Analysis & Forecast for Next 5 Years | Johnson & Johnson, Medtronic, Stryker | Bio-Implants
Bio-Implants Market will witness a 10% CAGR, Top Key Players and Forecast to 2030
Stay up to date with Bio-Implants Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.”... |
| 17.01.2022 | MicroPort CRM Receives Approval in Japan for Alizea Bluetooth Pacemaker | CLAMART, France, Jan. 16, 2022 /PRNewswire/ -- MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, recently received PMDA Japanese regulation agency approval for its latest range of implan... |
| 17.01.2022 | MicroPort Scientific : Endovastec™ Talos™ Thoracic Stent Graft System Receives NMPA Approval for Marketing | Shanghai, China, 15 January 2022 - Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec™) recently received a registration certificate from China's National Medical Products Administration (NMPA) for its independently devel... |
| 17.01.2022 | MicroPort CRM Receives Approval in Japan for Alizea Bluetooth Pacemaker | CLAMART, France, Jan. 17, 2022 /PRNewswire/ -- MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, recently received PMDA Japanese regulation agency approval for its latest range of implan... |
| 14.01.2022 | MicroPort Scientific : ® CRM Receives Approval in Japan for Alizea™ Bluetooth® Pacemaker | Clamart, France, 13 January 2022 - MicroPort® CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, recently received PMDA Japanese regulation agency approval for its latest range of implantable pacem... |
| 31.12.2021 | MicroPort Scientific : Endovastec™ Receives Approval for Hercules™-LP Stent Graft System in India | New Delhi, India, 31 December 2021 - Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec™) has recently received registration approval from the Indian Central Drugs Standard Control Organization (CDSCO) for its Hercules™ L... |
| 27.12.2021 | MicroPort Scientific : ® CRM Receives CE Mark Approval for NAVIGO™ Left Ventricular Pacing Leads | Clamart, France, 24 December 2021 - MicroPort CRM, a pioneering company in the field of Cardiac Rhythm management, headquartered in France, recently received CE Mark approval under the new Medical Device Regulation (MDR - 2017/745) for its ... |
| 27.12.2021 | MicroPort Scientific : ® Firehawk® Stent System Approved for Marketing in Australia | Canberra, Australia, 27 December 2021 - Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort®), a subsidiary of MicroPort Scientific Corporation, has recently received registration approval from the Australian Therapeutic Goods Administr... |
| 26.11.2021 | MicroPort Scientific : ® NeuroTech Obtains KGMP Certification | Seoul, South Korea, 26 November - MicroPort NeuroTech (Shanghai) Co., Ltd. (MicroPort® NeuroTech) recently received the Korea Good Manufacturing Practice (KGMP) certification, a quality system standard for medical devices in South Korea, fo... |
| 26.11.2021 | MicroPort Scientific : ® CRM Receives Approval in Japan for Alizea™ Bluetooth® Pacemaker | Clamart, France - 26 November, 2021 - MicroPort® CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, recently received PMDA Japanese regulation agency approval for its latest range of implantable pa... |
| 17.11.2021 | MicroPort Scientific : ® Announces Multiple Results from the TARGET Clinical Study on Firehawk® Stent at TCT 2021 | Orlando, USA, 17 November 2021 - MicroPort Scientific Corporation (MicroPort®) recently shared the latest progress of the TARGET series clinical trials for the Firehawk® Rapamycin Target Eluting Coronary Stent System (Firehawk®) at the 2021... |
| 11.11.2021 | MicroPort Scientific : ® Launches Firehawk IN™ as First Local India-manufactured DES for India Market | Mumbai, India, 11 November 2021 - Purple MicroPort Cardiovascular Private Limited (Purple MicroPort), an Indian joint venture company of MicroPort Scientific Corporation (MicroPort®) has officially launched for commercial sale the Firehawk ... |
| 02.11.2021 | MicroPort® Presents Argus OCT at the 32nd GW-ICC Entering the Era of Precision PCI | Beijing, China, 1 November 2021 - Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort®) recently joined the 32nd Great Wall International Congress of Cardiology (GW-ICC) to present the Argus intravascular OCT (Optical Coherence Tomograp... |
| 02.11.2021 | Top-tier Surgical Robot Company MicroPort MedBot Debuts on Main Board of HKEX | Hong Kong SAR/ Shanghai China, 2 November 2021 - Shanghai MicroPort® MedBot (Group) Co., Ltd. (02252.HK, "MicroPort MedBot" or "Company"), a subsidiary of MicroPort Scientific Corporation (00853.HK, "MicroPort®"... |
| 01.11.2021 | MicroPort® CardioFlow Medtech Launches VitaFlow Liberty™ at China Structural Week | Shanghai, China, 30 October 2021 - MicroPort CardioFlow Medtech Corp. ("CardioFlow Medtech") presented the VitaFlow Liberty™ Transcatheter Aortic Valve and Retrievable Delivery System ("VitaFlow Liberty™"), an independen... |
| 26.10.2021 | MicroPort® Hosts Teleconference of TARGET PREMIER Study on Next Generation Rapamycin Target Eluting Stent | Shanghai, China, 24 October 2021 - Researchers met remotely in a recent teleconference for the TARGET PREMIER project, a pre-market clinical study on the next-generation rapamycin target eluting coronary stent initiated by Shanghai MicroPor... |
| 25.10.2021 | MicroPort Scientific : ® CRM Announces Completion of Patient Recruitment for the Primary Objectives of the Apollo Study on Invicta Defibrillation Lead | Clamart, France- 15 October 2021 - MicroPort CRM, a pioneering company in Cardiac Rhythm Management (CRM) headquartered in France with global operations, today announced the completion of patient recruitment in the Apollo clinical study aim... |
| 05.10.2021 | MicroPort Scientific : ® Purchases Property at Heart of Zhangjiang Science City for its Miracle Point Innovation Center for New Materials and Medical Devices | Shanghai, China-MicroPort Scientific Corporation (00853.HK, "MicroPort®") recently announced that its subsidiary, MicroPort (Shanghai) Scientific Investment Co., Ltd. ("MicroPort® Investment"), has concluded an agreement... |
| 05.10.2021 | Seed Fonds Aachen II veräußert Anteile an Aachener MedTech-Unternehmen Hemovent | wir freuen uns, mit dem Verkauf der Hemovent GmbH heute den dritten erfolgreichen Exit des Seed Fonds Aachen II (Vorläuferfonds unseres TechVision Fonds) in diesem Jahr bekannt zu geben. |
| 04.10.2021 | MicroPort Scientific : ® Acquires German ECLS Company Hemovent® GmbH and Invests in Expansion of German Operations | Shanghai, China & Aachen, Germany - MicroPort Scientific Corporation (hereinafter referred to as "MicroPort®") announced on October 4th, 2021, through its critical care subsidiary, MicroPort Surgical B.V. ("MicroPort® Sur... |
| 13.09.2021 | MicroPort Scientific : ® Announces Strategic Investment with Kerui Pharma | Shanghai, China, 10 September 2021 - MicroPort Scientific Corporation (MicroPort®) announced that its subsidiary, Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort® Shanghai), entered into an equity acquisition agreement with Fujian 6... |
| 30.08.2021 | MicroPort Scientific : ® EP OptimAblate™ Tubing Set Receives NMPA Marketing Approval | Shanghai, China, 30 August 2021 - Shanghai MicroPort EP MedTech Co., Ltd., (MicroPort® EP), has recently received marketing approval from China's National Medical Products Administration (NMPA) for its self-developed OptimAblate™ Tubing Set... |
| 10.08.2021 | MicroPort Scientific : Endovastec™ Receives ISO 50001 Energy Management System Certificate | Shanghai, China, 09 August 2021 - Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec™) has obtained the ISO 50001:2018 Energy Management System Certificate after passing the assessment by the Conformity Assessment Certifi... |
| 04.08.2021 | MicroPort Scientific : ® Wewin Receives CE Mark for its 2019-nCoV PCR Test Kit | Shanghai, China, 03 August 2021 - MicroPort® Wewin Diagnostics Co., Ltd (MicroPort® Wewin) recently received the CE mark for its self-developed real-time PCR test, SARS-CoV-2 Nucleic Acid Test Kit (PCR Test Kit).
The PCR Test Kit developed ... |
| 30.07.2021 | MicroPort Scientific : CardioFlow Medtech Makes Follow-on Investment in Transcatheter Valve Start-up Valcare | Shanghai, China, 30 July 2021 - MicroPort® CardioFlow Medtech Corporation (CardioFlow Medtech) has recently entered into a simple agreement for future equity (SAFE) with Valcare, Inc. (Valcare), a start-up focusing on innovative transcathet... |
| 27.07.2021 | MicroPort :® Cardiac Rhythm Management Business Announces US$150 Million Series C Investment | SHANGHAI, July 27, 2021 /PRNewswire/ -- MicroPort Scientific Corporation ("MicroPort®") announced that MicroPort Cardiac Rhythm Management Limited ("MicroPort® CRM"), which is MicroPort®'s subsidiary focused on developin... |
| 27.07.2021 | MicroPort® Cardiac Rhythm Management Business Announces US$150 Million Series C Investment | SHANGHAI, July 27, 2021 /PRNewswire/ -- MicroPort Scientific Corporation ("MicroPort®") announced that MicroPort Cardiac Rhythm Management Limited ("MicroPort® CRM"), which is MicroPort®'s subsidiary focused on developin... |
| 02.07.2021 | MicroPort Scientific : ® Orthopedics Receives “15A” ODEP Rating for its Advance® Medial-Pivot Knee System | Shanghai, China, 30 June 2021 - MicroPort® Orthopedics received a '15A' rating from the Orthopedic Data Evaluation Panel (ODEP) for its independently-developed Advance® Medial-Pivot Knee System.
Established in the United Kingdom in 2002, OD... |
| 25.06.2021 | MicroPort Scientific : ® Listed Among “China's 500 Most Valuable Brands” List Again for 2021 | Beijing, China - For the second time, MicroPort Scientific Corporation (HK00853, 'MicroPort®') has been listed among 'China's 500 Most Valuable Brands' for 2021 with a brand value of RMB 10.365 billion. The list, together with the analysis ... |
| 18.06.2021 | MicroPort Scientific : Firehawk® Receives Registration Approval in Venezuela | Caracas, Venezuela, 22 June 2021 - The Firehawk® Rapamycin Target Eluting Coronary Stent System (Firehawk®), a product of Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort®), has received registration approval from the Venezuelan auth... |
| 17.06.2021 | MICROPORT SCIENTIFIC CORPORATION
MicroPort Scientific : CRM announces European launch of Alizea™ and Borea™ pacemakers with Bluetooth® connectivity and streamlined remote monitoring | Clamart, France -on June 17, 2021 - MicroPort CRM, a pioneering company in the field of Cardiac Rhythm management, headquartered in France with global operations, announced today the European launch of AlizeaTM and BoreaTM pacemakers after ... |
| 11.06.2021 | MICROPORT SCIENTIFIC CORPORATION
MicroPort Scientific : ® Participates in OCC 2021 and Announces One-Year Results of Firesorb® Pivotal Study FUTURE-II | Shanghai, China - Recently, Shanghai Microport Medical (Group) Co., Ltd (MicroPort®) recently participated in the 15th Oriental Congress of Cardiology (OCC 2021) to present the key imaging and clinical results of the FUTURE-II trial - a piv... |
| 03.06.2021 | MICROPORT SCIENTIFIC CORPORATION
MicroPort Scientific : ® CRM announces the First Patients Enrolled in the European TARGET FIRST Clinical Trial of the FirehawkTM Coronary Stent | Clamart, France - June 3rd, 2021 - MicroPort® CRM today announced the first enrollments in the European TARGET FIRST trial - a prospective, randomized, controlled, multi-centre clinical trial involving 2200 patients from up to 50 clinical c... |
| 01.06.2021 | MICROPORT SCIENTIFIC CORPORATION
MicroPort Scientific : ® EP Receives Registration Approval from Kazakhstan Ministry of Health for Multiple Products | Shanghai, China, 20 May 2021 - Shanghai MicroPort EP MedTech Co., Ltd. ('MicroPort® EP') has recently obtained registration approval from the Ministry of Health of Kazakhstan ('MOH') for multiple independently-developed products, marking it... |
| 31.05.2021 | MICROPORT SCIENTIFIC CORPORATION
MicroPort Scientific : ® Launches Multiple Symposia at CIT 2021 | Beijing, China, 28 May 2021- Shanghai MicroPort® Medical (Group) Co., Ltd. (MicroPort®) recently attended the 19th Annual Chinese Interventional Therapeutic Congress, 'Collaboration, Innovation, Transition' (CIT 2021), and launched multiple... |
| 13.05.2021 | MicroPort Scientific : Subject Enrollment Completed for Clinical Trial of MicroPort®️ EP Contact Force-Sensing Catheter | Ningbo, China, 12 May 2021 -Subject enrollment for the pre-market clinical trial of the MicroPort® Contact Force-Sensing RF Ablation Catheter ('Contact Force-Sensing Catheter'), developed by Shanghai MicroPort EP MedTech Co., Ltd. ('MicroPo... |
| 03.05.2021 | MICROPORT SCIENTIFIC CORPORATION
MicroPort Scientific : ® NeuroTech Closes Equity Investment in Rapid Medical, Becoming the First Majority Shareholder | Shanghai, China-Shanghai MicroPort® NeuroTech Co., Ltd. ('MicroPort® NeuroTech'), a subsidiary of MicroPort Scientific Corporation (00853.HK), has recently closed an equity investment deal with Rapid Medical. As the lead investor in the Ser... |
| 28.04.2021 | MICROPORT SCIENTIFIC CORPORATION
MicroPort Scientific : CRM receives CE mark approval for AlizeaTM and BoreaTM pacemakers under the new European Medical Device Regulation | Clamart, France -April 28- MicroPort CRM, a pioneering company in the field of Cardiac Rhythm management, headquartered in France with global operations, announces it has received CE Mark approval under the new MDR (Medical Device Regulatio... |
| 02.04.2021 | MICROPORT SCIENTIFIC CORPORATION
MicroPort Scientific : ® Announces its Annual Results for 2020 | Shanghai, China - MicroPort Scientific Corporation (hereafter referred to as the 'Company' or 'Microport®', stock code: 00853) announced on March 30 the annual results of the Company and its subsidiaries (hereafter referred to as the 'Group... |
| 02.04.2021 | MicroPort Scientific : ® Announces its Annual Results for 2020 | Shanghai, China - MicroPort Scientific Corporation (hereafter referred to as the 'Company' or 'Microport®', stock code: 00853) announced on March 30 the annual results of the Company and its subsidiaries (hereafter referred to as the 'Group... |
| 04.09.2020 | Hillhouse leads $512m investment in MicroPort’s surgical robotics unit | Premium
A consortium led by Asia-focused private equity powerhouse Hillhouse Capital has invested 3.5 billion yuan ($512 million) in MicroPort MedBot, the surgical robotic solution unit of medical device developer MicroPort.
Continue readin... |
| 09.06.2020 | Top 10 companies that have raised funding in the men's health space | While funding women's health startups is rising, men's health so far isn't seeing the same boost
Funding for women's health startups is on the rise after traditionally lagging behind. While that's a great thing, the same can't be said for s... |
| 17.04.2020 | HK-listed MicroPort’s heart valve unit nets $130m from Hillhouse, Lake Bleu, others | Premium
MicroPort CardioFlow Medtech, a subsidiary of Hong Kong-listed medical device developer MicroPort Scientific Corporation, has raised $130 million in a new funding round at a pre-money valuation of $1.1 billion.
Continue reading this... |
| 06.10.2015 | Onkos Surgical Closes Series A Financing | Onkos Surgical, a Parsipanny, NJ-based surgical oncology startup, closed a Series A round of financing.
The amount of the deal was not disclosed.
The round was led by 1315 Capital.
Founded in 2015 by CEO Patrick Treacy, Antony Koblish and 1... |